PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Top Cited Papers
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 6 (2), 117-127
- https://doi.org/10.1016/j.ccr.2004.06.022
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT CascadesJournal of Biological Chemistry, 2003
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Tumor Suppressor PTEN Mediates Sensing of Chemoattractant GradientsCell, 2002
- Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityOncogene, 2002
- Antibodies Stage a Comeback in Cancer TreatmentScience, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinicJournal of Clinical Immunology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985